{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:10:21Z","timestamp":1777738221478,"version":"3.51.4"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:00:00Z","timestamp":1607385600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2012\/06\/A\/NZ1\/00004"],"award-info":[{"award-number":["2012\/06\/A\/NZ1\/00004"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/21\/B\/NZ1\/00293"],"award-info":[{"award-number":["2016\/21\/B\/NZ1\/00293"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/30\/A\/NZ3\/00412"],"award-info":[{"award-number":["2018\/30\/A\/NZ3\/00412"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University","award":["BMN 7\/2017"],"award-info":[{"award-number":["BMN 7\/2017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Skeletal Muscle"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The nuclear factor erythroid 2-related factor 2 (Nrf2) is considered as a master cytoprotective factor regulating the expression of genes encoding anti-oxidant, anti-inflammatory, and detoxifying proteins. The role of Nrf2 in the pathophysiology of skeletal muscles has been evaluated in different experimental models, however, due to inconsistent data, we aimed to investigate how Nrf2 transcriptional deficiency (Nrf2\n                    <jats:sup>tKO<\/jats:sup>\n                    ) affects muscle functions both in an acute and chronic injury. The acute muscle damage was induced in mice of two genotypes\u2014WT and Nrf2\n                    <jats:sup>tKO<\/jats:sup>\n                    mice by cardiotoxin (CTX) injection. To investigate the role of Nrf2 in chronic muscle pathology,\n                    <jats:italic>mdx<\/jats:italic>\n                    mice that share genetic, biochemical, and histopathological features with Duchenne muscular dystrophy (DMD) were crossed with mice lacking transcriptionally active Nrf2 and double knockouts (\n                    <jats:italic>mdx<\/jats:italic>\n                    \/Nrf2\n                    <jats:sup>tKO<\/jats:sup>\n                    ) were generated. To worsen the dystrophic phenotype, the analysis of disease pathology was also performed in aggravated conditions, by applying a long-term treadmill test. We have observed slightly increased muscle damage in Nrf2\n                    <jats:sup>tKO<\/jats:sup>\n                    mice after CTX injection. Nevertheless, transcriptional ablation of Nrf2 in\n                    <jats:italic>mdx<\/jats:italic>\n                    mice did not significantly aggravate the most deleterious, pathological hallmarks of DMD related to degeneration, inflammation, fibrotic scar formation, angiogenesis, and the number and proliferation of satellite cells in non-exercised conditions. On the other hand, upon chronic exercises, the degeneration and inflammatory infiltration of the gastrocnemius muscle, but not the diaphragm, turned to be increased in Nrf2\n                    <jats:sup>tKO<\/jats:sup>\n                    <jats:italic>mdx<\/jats:italic>\n                    in comparison to\n                    <jats:italic>mdx<\/jats:italic>\n                    mice. In conclusion, the lack of transcriptionally active Nrf2 influences moderately muscle pathology in acute CTX-induced muscle injury and chronic DMD mouse model, without affecting muscle functionality. Hence, in general, we demonstrated that the deficiency of Nrf2 transcriptional activity has no profound impact on muscle pathology in various models of muscle injury.\n                  <\/jats:p>","DOI":"10.1186\/s13395-020-00255-0","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T00:50:03Z","timestamp":1607388603000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The role of Nrf2 in acute and chronic muscle injury"],"prefix":"10.1186","volume":"10","author":[{"given":"Iwona","family":"Bronisz-Budzy\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Kozakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Podkalicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neli","family":"Kachamakova-Trojanowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"\u0141oboda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5687-0839","authenticated-orcid":false,"given":"J\u00f3zef","family":"Dulak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,8]]},"reference":[{"issue":"9307","key":"255_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(02)07815-7","volume":"359","author":"AE Emery","year":"2002","unstructured":"Emery AE. The muscular dystrophies. The Lancet. 2002;359(9307):687\u201395.","journal-title":"The Lancet."},{"issue":"5","key":"255_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/ana.23982","volume":"74","author":"JR Mendell","year":"2013","unstructured":"Mendell JR, Rodino-Klapac LR, Sahenk Z, Roush K, Bird L, Lowes LP, et al. Eteplirsen for the treatment of Duchenne muscular dystrophy: eteplirsen for DMD. Ann Neurol. 2013;74(5):637\u201347.","journal-title":"Ann Neurol."},{"issue":"1","key":"255_CR3","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/mus.880170103","volume":"17","author":"K Matsumura","year":"1994","unstructured":"Matsumura K, Campbell KP. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve. 1994;17(1):2\u201315.","journal-title":"Muscle Nerve."},{"issue":"299","key":"255_CR4","doi-asserted-by":"publisher","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","volume":"7","author":"AS Rosenberg","year":"2015","unstructured":"Rosenberg AS, Puig M, Nagaraju K, Hoffman EP, Villalta SA, Rao VA, et al. Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med. 2015 Aug 5;7(299):299rv4.","journal-title":"Sci Transl Med"},{"key":"255_CR5","doi-asserted-by":"crossref","unstructured":"Tidball JG. Mechanisms of muscle injury, repair, and regeneration. In: Terjung R, editor. Comprehensive Physiology [Internet]. Hoboken, NJ, USA: John Wiley & Sons, Inc.; 2011 [cited 2020 Mar 26]. p. c100092. Available from: http:\/\/doi.wiley.com\/10.1002\/cphy.c100092.","DOI":"10.1002\/cphy.c100092"},{"issue":"2","key":"255_CR6","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1006\/clim.2000.4966","volume":"98","author":"MJ Spencer","year":"2001","unstructured":"Spencer MJ, Montecino-Rodriguez E, Dorshkind K, Tidball JG. Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle. Clinical Immunology. 2001 Feb;98(2):235\u201343.","journal-title":"Clinical Immunology."},{"issue":"4","key":"255_CR7","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1152\/japplphysiol.01145.2006","volume":"102","author":"JG Tidball","year":"2007","unstructured":"Tidball JG, Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. Journal of Applied Physiology. 2007 Apr;102(4):1677\u201386.","journal-title":"Journal of Applied Physiology."},{"issue":"1","key":"255_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/S0960-8966(97)00124-7","volume":"8","author":"TA Rando","year":"1998","unstructured":"Rando TA, Disatnik M-H, Yu Y, Franco A. Muscle cells from mdx mice have an increased susceptibility to oxidative stress. Neuromuscular Disorders. 1998 Feb;8(1):14\u201321.","journal-title":"Neuromuscular Disorders."},{"issue":"2","key":"255_CR9","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/ars.2017.7435","volume":"29","author":"K Pietraszek-Gremplewicz","year":"2018","unstructured":"Pietraszek-Gremplewicz K, Kozakowska M, Bronisz-Budzynska I, Ciesla M, Mucha O, Podkalicka P, et al. Heme oxygenase-1 influences satellite cells and progression of Duchenne muscular dystrophy in mice. Antioxidants & Redox Signaling. 2018 Jul 10;29(2):128\u201348.","journal-title":"Antioxidants & Redox Signaling."},{"issue":"2","key":"255_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ajpath.2017.10.017","volume":"188","author":"M Kozakowska","year":"2018","unstructured":"Kozakowska M, Pietraszek-Gremplewicz K, Ciesla M, Seczynska M, Bronisz-Budzynska I, Podkalicka P, et al. Lack of heme oxygenase-1 induces inflammatory reaction and proliferation of muscle satellite cells after cardiotoxin-induced skeletal muscle injury. The American Journal of Pathology. 2018 Feb;188(2):491\u2013506.","journal-title":"The American Journal of Pathology."},{"issue":"37","key":"255_CR11","doi-asserted-by":"publisher","first-page":"26071","DOI":"10.1074\/jbc.274.37.26071","volume":"274","author":"J Alam","year":"1999","unstructured":"Alam J, Stewart D, Touchard C, Boinapally S, Choi AMK, Cook JL. Nrf2, a cap\u2019n\u2019collar transcription factor, regulates induction of the heme oxygenase-1 gene. J Biol Chem. 1999 Sep 10;274(37):26071\u20138.","journal-title":"J Biol Chem."},{"issue":"112","key":"255_CR12","doi-asserted-by":"publisher","first-page":"re3","DOI":"10.1126\/scisignal.3112re3","volume":"3","author":"GP Sykiotis","year":"2010","unstructured":"Sykiotis GP, Bohmann D. Stress-activated cap\u2019n\u2019collar transcription factors in aging and human disease. Science Signaling. 2010 Mar 9;3(112):re3.","journal-title":"Science Signaling"},{"key":"255_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.redox.2018.04.004","volume":"17","author":"B Ahn","year":"2018","unstructured":"Ahn B, Pharaoh G, Premkumar P, Huseman K, Ranjit R, Kinter M, et al. Nrf2 deficiency exacerbates age-related contractile dysfunction and loss of skeletal muscle mass. Redox Biol. 2018;17:47\u201358.","journal-title":"Redox Biol."},{"key":"255_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.redox.2016.10.003","volume":"10","author":"AJ Done","year":"2016","unstructured":"Done AJ, Traustad\u00f3ttir T. Nrf2 mediates redox adaptations to exercise. Redox Biol. 2016;10:191\u20139.","journal-title":"Redox Biol."},{"key":"255_CR15","doi-asserted-by":"crossref","unstructured":"Petrillo S, Pelosi L, Piemonte F, Travaglini L, Forcina L, Catteruccia M, et al. Oxidative stress in Duchenne muscular dystrophy: focus on the NRF2 redox pathway. Hum Mol Genet. 2017 15;26(14):2781\u20132790.","DOI":"10.1093\/hmg\/ddx173"},{"issue":"29","key":"255_CR16","doi-asserted-by":"publisher","first-page":"17784","DOI":"10.1074\/jbc.M115.655019","volume":"290","author":"C-C Sun","year":"2015","unstructured":"Sun C-C, Li S-J, Yang C-L, Xue R-L, Xi Y-Y, Wang L, et al. Sulforaphane attenuates muscle inflammation in dystrophin-deficient mdx mice via NF-E2-related factor 2 (Nrf2)-mediated inhibition of NF-\u03baB signaling pathway. J Biol Chem. 2015;290(29):17784\u201395.","journal-title":"J Biol Chem."},{"issue":"4","key":"255_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1152\/japplphysiol.00721.2015","volume":"120","author":"C Sun","year":"2016","unstructured":"Sun C, Li S, Li D. Sulforaphane mitigates muscle fibrosis in mdx mice via Nrf2-mediated inhibition of TGF-\u03b2\/Smad signaling. Journal of Applied Physiology. 2016;120(4):377\u201390.","journal-title":"Journal of Applied Physiology."},{"issue":"2","key":"255_CR18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1152\/japplphysiol.00744.2014","volume":"118","author":"C Sun","year":"2015","unstructured":"Sun C, Yang C, Xue R, Li S, Zhang T, Pan L, et al. Sulforaphane alleviates muscular dystrophy in mdx mice by activation of Nrf2. Journal of Applied Physiology. 2015;118(2):224\u201337.","journal-title":"Journal of Applied Physiology."},{"issue":"2","key":"255_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","volume":"236","author":"K Itoh","year":"1997","unstructured":"Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, et al. An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313\u201322.","journal-title":"Biochem Biophys Res Commun."},{"issue":"7","key":"255_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011838","volume":"5","author":"NG Innamorato","year":"2010","unstructured":"Innamorato NG, Jazwa A, Rojo AI, Garc\u00eda C, Fern\u00e1ndez-Ruiz J, Grochot-Przeczek A, et al. Different susceptibility to the Parkinson\u2019s toxin MPTP in mice lacking the redox master regulator Nrf2 or its target gene heme oxygenase-1. PLoS ONE. 2010;5(7):e11838.","journal-title":"PLoS ONE."},{"issue":"14","key":"255_CR21","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1089\/ars.2018.7505","volume":"30","author":"D Kloska","year":"2019","unstructured":"Kloska D, Kopacz A, Cysewski D, Aepfelbacher M, Dulak J, Jozkowicz A, et al. Nrf2 sequesters Keap1 preventing podosome disassembly: a quintessential duet moonlights in endothelium. Antioxid Redox Signal. 2019;30(14):1709\u201330.","journal-title":"Antioxid Redox Signal."},{"key":"255_CR22","doi-asserted-by":"crossref","unstructured":"Bronisz-Budzy\u0144ska I, Chwalenia K, Mucha O, Podkalicka P, Karolina-Bukowska-Strakova, J\u00f3zkowicz A, et al. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skeletal Muscle. 2019 Dec;9(1):22.","DOI":"10.1186\/s13395-019-0207-0"},{"issue":"8","key":"255_CR23","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/hmg\/ddu735","volume":"24","author":"C Giordano","year":"2015","unstructured":"Giordano C, Mojumdar K, Liang F, Lemaire C, Li T, Richardson J, et al. Toll-like receptor 4 ablation in mdx mice reveals innate immunity as a therapeutic target in Duchenne muscular dystrophy. Human Molecular Genetics. 2015;24(8):2147\u201362.","journal-title":"Human Molecular Genetics."},{"issue":"6","key":"255_CR24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1172\/JCI62656","volume":"122","author":"N Liu","year":"2012","unstructured":"Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, et al. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest. 2012;122(6):2054\u201365.","journal-title":"J Clin Invest."},{"issue":"15","key":"255_CR25","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1093\/hmg\/ddu113","volume":"23","author":"Y Nitahara-Kasahara","year":"2014","unstructured":"Nitahara-Kasahara Y, Hayashita-Kinoh H, Chiyo T, Nishiyama A, Okada H, Takeda S, et al. Dystrophic mdx mice develop severe cardiac and respiratory dysfunction following genetic ablation of the anti-inflammatory cytokine IL-10. Human Molecular Genetics. 2014;23(15):3990\u20134000.","journal-title":"Human Molecular Genetics."},{"issue":"4\u20135","key":"255_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0960-8966(99)00126-1","volume":"10","author":"JA Granchelli","year":"2000","unstructured":"Granchelli JA, Pollina C, Hudecki MS. Pre-clinical screening of drugs using the mdx mouse. Neuromuscular Disorders. 2000;10(4\u20135):235\u20139.","journal-title":"Neuromuscular Disorders."},{"issue":"1","key":"255_CR27","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.102.041343","volume":"304","author":"A De Luca","year":"2003","unstructured":"De Luca A, Pierno S, Liantonio A, Cetrone M, Camerino C, Fraysse B, et al. Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1. J Pharmacol Exp Ther. 2003;304(1):453\u201363.","journal-title":"J Pharmacol Exp Ther."},{"key":"255_CR28","first-page":"51303","volume":"85","author":"A Aartsma-Rus","year":"2014","unstructured":"Aartsma-Rus A, van Putten M. Assessing functional performance in the mdx mouse model. JoVE. 2014;85:51303.","journal-title":"JoVE."},{"issue":"1","key":"255_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2044-5040-4-21","volume":"4","author":"LR Smith","year":"2014","unstructured":"Smith LR, Barton ER. SMASH \u2013 semi-automatic muscle analysis using segmentation of histology: a MATLAB application. Skeletal Muscle. 2014;4(1):21.","journal-title":"Skeletal Muscle."},{"issue":"12","key":"255_CR30","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.3390\/ijms18122772","volume":"18","author":"S Vomund","year":"2017","unstructured":"Vomund S, Sch\u00e4fer A, Parnham M, Br\u00fcne B, von Knethen A. Nrf2, the master regulator of anti-oxidative responses. IJMS. 2017;18(12):2772.","journal-title":"IJMS."},{"issue":"1","key":"255_CR31","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016;7(1):11624.","journal-title":"Nat Commun."},{"issue":"1","key":"255_CR32","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1038\/s41467-018-06068-6","volume":"9","author":"B Malecova","year":"2018","unstructured":"Malecova B, Gatto S, Etxaniz U, Passafaro M, Cortez A, Nicoletti C, et al. Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy. Nat Commun. 2018;9(1):3670.","journal-title":"Nat Commun."},{"issue":"8","key":"255_CR33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00018-019-03006-7","volume":"76","author":"P Podkalicka","year":"2019","unstructured":"Podkalicka P, Mucha O, Dulak J, Loboda A. Targeting angiogenesis in Duchenne muscular dystrophy. Cell Mol Life Sci. 2019;76(8):1507\u201328.","journal-title":"Cell Mol Life Sci."},{"issue":"11","key":"255_CR34","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1089\/ars.2013.5219","volume":"20","author":"U Florczyk","year":"2014","unstructured":"Florczyk U, Jazwa A, Maleszewska M, Mendel M, Szade K, Kozakowska M, et al. Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia. Antioxid Redox Signal. 2014;20(11):1693\u2013708.","journal-title":"Antioxid Redox Signal."},{"issue":"2","key":"255_CR35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ng1725","volume":"38","author":"J-F Chen","year":"2006","unstructured":"Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet. 2006;38(2):228\u201333.","journal-title":"Nat Genet."},{"issue":"1","key":"255_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2044-5040-4-7","volume":"4","author":"P Pessina","year":"2014","unstructured":"Pessina P, Cabrera D, Morales M, Riquelme CA, Guti\u00e9rrez J, Serrano AL, et al. Novel and optimized strategies for inducing fibrosis in vivo: focus on Duchenne muscular dystrophy. Skeletal Muscle. 2014;4(1):7.","journal-title":"Skeletal Muscle."},{"issue":"6","key":"255_CR37","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI37662","volume":"119","author":"SA Vetrone","year":"2009","unstructured":"Vetrone SA, Montecino-Rodriguez E, Kudryashova E, Kramerova I, Hoffman EP, Liu SD, et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-\u03b2. J Clin Invest. 2009;119(6):1583\u201394.","journal-title":"J Clin Invest."},{"issue":"10119","key":"255_CR38","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","volume":"391","author":"CM McDonald","year":"2018","unstructured":"McDonald CM, Henricson EK, Abresch RT, Duong T, Joyce NC, Hu F, et al. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study. The Lancet. 2018;391(10119):451\u201361.","journal-title":"The Lancet."},{"issue":"1","key":"255_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/archdischild-2015-308654","volume":"101","author":"CL Wood","year":"2016","unstructured":"Wood CL, Straub V, Guglieri M, Bushby K, Cheetham T. Short stature and pubertal delay in Duchenne muscular dystrophy. Arch Dis Child. 2016;101(1):101\u20136.","journal-title":"Arch Dis Child."},{"issue":"2","key":"255_CR40","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1172\/JCI116661","volume":"92","author":"K Matsumura","year":"1993","unstructured":"Matsumura K, Tom\u00e9 FM, Ionasescu V, Ervasti JM, Anderson RD, Romero NB, et al. Deficiency of dystrophin-associated proteins in Duchenne muscular dystrophy patients lacking COOH-terminal domains of dystrophin. J Clin Invest. 1993;92(2):866\u201371.","journal-title":"J Clin Invest."},{"issue":"2","key":"255_CR41","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1083\/jcb.139.2.375","volume":"139","author":"V Straub","year":"1997","unstructured":"Straub V, Rafael JA, Chamberlain JS, Campbell KP. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J Cell Biol. 1997;139(2):375\u201385.","journal-title":"J Cell Biol."},{"issue":"5","key":"255_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1096\/fj.201500153","volume":"30","author":"SB Shelar","year":"2016","unstructured":"Shelar SB, Narasimhan M, Shanmugam G, Litovsky SH, Gounder SS, Karan G, et al. Disruption of nuclear factor (erythroid-derived-2)\u2013like 2 antioxidant signaling: a mechanism for impaired activation of stem cells and delayed regeneration of skeletal muscle. The FASEB Journal. 2016;30(5):1865\u201379.","journal-title":"The FASEB Journal."},{"issue":"12","key":"255_CR43","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/embor.2013.182","volume":"14","author":"CF Bentzinger","year":"2013","unstructured":"Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA. Cellular dynamics in the muscle satellite cell niche. EMBO Rep. 2013;14(12):1062\u201372.","journal-title":"EMBO Rep."},{"issue":"26","key":"255_CR44","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1182\/blood-2017-10-812941","volume":"132","author":"JJ Tsai","year":"2018","unstructured":"Tsai JJ, Velardi E, Shono Y, Argyropoulos KV, Holland AM, Smith OM, et al. Nrf2 regulates CD4+ T cell\u2013induced acute graft-versus-host disease in mice. Blood. 2018;132(26):2763\u201374.","journal-title":"Blood."},{"issue":"2","key":"255_CR45","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1083\/jcb.201510086","volume":"213","author":"J Capote","year":"2016","unstructured":"Capote J, Kramerova I, Martinez L, Vetrone S, Barton ER, Sweeney HL, et al. Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype. Journal of Cell Biology. 2016;213(2):275\u201388.","journal-title":"Journal of Cell Biology."},{"key":"255_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.fct.2018.08.067","volume":"121","author":"AP Boss","year":"2018","unstructured":"Boss AP, Freeborn RA, Duriancik DM, Kennedy RC, Gardner EM, Rockwell CE. The Nrf2 activator tBHQ inhibits the activation of primary murine natural killer cells. Food and Chemical Toxicology. 2018;121:231\u20136.","journal-title":"Food and Chemical Toxicology."},{"issue":"1","key":"255_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.febslet.2013.11.009","volume":"588","author":"J Kang","year":"2014","unstructured":"Kang J, Jeong MG, Oh S, Jang EJ, Kim HK, Hwang ES. A FoxO1-dependent, but NRF2-independent induction of heme oxygenase-1 during muscle atrophy. FEBS Letters. 2014;588(1):79\u201385.","journal-title":"FEBS Letters."},{"issue":"7","key":"255_CR48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","volume":"68","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Mayer M, Leturcq F, Barbet J-P, Gherardi RK, Christov C. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol. 2009;68(7):762\u201373.","journal-title":"J Neuropathol Exp Neurol."},{"key":"255_CR49","doi-asserted-by":"crossref","unstructured":"Ishitobi M, Haginoya K, Zhao Y, Ohnuma A, Minato J, Yanagisawa T, et al. Elevated plasma levels of transforming growth factor \u03b21 in patients with muscular dystrophy: NeuroReport. 2000 Dec;11(18):4033\u20135.","DOI":"10.1097\/00001756-200012180-00026"},{"issue":"4","key":"255_CR50","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/path.4801","volume":"240","author":"N Ieronimakis","year":"2016","unstructured":"Ieronimakis N, Hays A, Prasad A, Janebodin K, Duffield JS, Reyes M. PDGFR\u03b1 signalling promotes fibrogenic responses in collagen-producing cells in Duchenne muscular dystrophy: PDGFR\u03b1 signalling promotes fibrosis in Duchenne muscular dystrophy. J Pathol. 2016;240(4):410\u201324.","journal-title":"J Pathol."},{"key":"255_CR51","doi-asserted-by":"crossref","unstructured":"Gaiad TP, Araujo KPC, Serr\u00e3o JC, Miglino MA, Ambr\u00f3sio CE. Motor physical therapy affects muscle collagen type I and decreases gait speed in dystrophin-deficient dogs. Huard J, editor. PLoS ONE. 2014 Apr 8;9(4):e93500.","DOI":"10.1371\/journal.pone.0093500"},{"issue":"11","key":"255_CR52","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1096\/fj.03-1127fje","volume":"18","author":"H-Y Cho","year":"2004","unstructured":"Cho H-Y, Reddy SPM, Yamamoto M, Kleeberger SR. The transcription factor NRF2 protects against pulmonary fibrosis. The FASEB Journal. 2004;18(11):1258\u201360.","journal-title":"The FASEB Journal."},{"issue":"10","key":"255_CR53","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1097\/MPA.0000000000001433","volume":"48","author":"GG Kojayan","year":"2019","unstructured":"Kojayan GG, Alizadeh RF, Li S, Ichii H. Reducing pancreatic fibrosis using antioxidant therapy targeting Nrf2 antioxidant pathway: a possible treatment for chronic pancreatitis. Pancreas. 2019;48(10):1259\u201362.","journal-title":"Pancreas."},{"issue":"3","key":"255_CR54","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/mnfr.201200456","volume":"57","author":"A Stachurska","year":"2013","unstructured":"Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, et al. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res. 2013;57(3):504\u201315.","journal-title":"Mol Nutr Food Res."},{"issue":"2","key":"255_CR55","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/jcp.27040","volume":"234","author":"Y Takemoto","year":"2019","unstructured":"Takemoto Y, Inaba S, Zhang L, Tsujikawa K, Uezumi A, Fukada S. Implication of basal lamina dependency in survival of Nrf2-null muscle stem cells via an antioxidative-independent mechanism. J Cell Physiol. 2019;234(2):1689\u201398.","journal-title":"J Cell Physiol."},{"key":"255_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/184393","volume":"2011","author":"A Nakamura","year":"2011","unstructured":"Nakamura A, Takeda S. Mammalian models of Duchenne muscular dystrophy: pathological characteristics and therapeutic applications. Journal of Biomedicine and Biotechnology. 2011;2011:1\u20138.","journal-title":"Journal of Biomedicine and Biotechnology."},{"issue":"1","key":"255_CR57","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41536-018-0045-4","volume":"3","author":"N Yucel","year":"2018","unstructured":"Yucel N, Chang AC, Day JW, Rosenthal N, Blau HM. Humanizing the mdx mouse model of DMD: the long and the short of it. NPJ Regen Med. 2018 Dec;3(1):4.","journal-title":"NPJ Regen Med"},{"issue":"3","key":"255_CR58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","volume":"8","author":"JW McGreevy","year":"2015","unstructured":"McGreevy JW, Hakim CH, McIntosh MA, Duan D. Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Disease Models & Mechanisms. 2015;8(3):195\u2013213.","journal-title":"Disease Models & Mechanisms."},{"issue":"5\u20136","key":"255_CR59","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/0960-8966(93)90098-5","volume":"3","author":"JP Louboutin","year":"1993","unstructured":"Louboutin JP, Fichter-Gagnepain V, Thaon E, Fardeau M. Morphometric analysis of mdx diaphragm muscle fibres. Comparison with hindlimb muscles. Neuromuscular Disorders. 1993;3(5\u20136):463\u20139.","journal-title":"Neuromuscular Disorders."},{"issue":"8","key":"255_CR60","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0960-8966(97)00115-6","volume":"7","author":"V Brussee","year":"1997","unstructured":"Brussee V, Tardif F, Tremblay JP. Muscle fibers of mdx mice are more vulnerable to exercise than those of normal mice. Neuromuscular Disorders. 1997;7(8):487\u201392.","journal-title":"Neuromuscular Disorders."},{"issue":"16","key":"255_CR61","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1242\/dev.069088","volume":"139","author":"F Relaix","year":"2012","unstructured":"Relaix F, Zammit PS. Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development. 2012;139(16):2845\u201356.","journal-title":"Development."},{"issue":"Pt 12","key":"255_CR62","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1242\/jcs.113.12.2299","volume":"113","author":"L Heslop","year":"2000","unstructured":"Heslop L, Morgan JE, Partridge TA. Evidence for a myogenic stem cell that is exhausted in dystrophic muscle. J Cell Sci. 2000;113(Pt 12):2299\u2013308.","journal-title":"J Cell Sci."},{"issue":"1","key":"255_CR63","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/dvdy.20602","volume":"235","author":"Z Yablonka-Reuveni","year":"2006","unstructured":"Yablonka-Reuveni Z, Anderson JE. Satellite cells from dystrophic (Mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers. Dev Dyn. 2006;235(1):203\u201312.","journal-title":"Dev Dyn."},{"issue":"1","key":"255_CR64","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13395-015-0046-6","volume":"5","author":"S Schiaffino","year":"2015","unstructured":"Schiaffino S, Rossi AC, Smerdu V, Leinwand LA, Reggiani C. Developmental myosins: expression patterns and functional significance. Skeletal Muscle. 2015;5(1):22.","journal-title":"Skeletal Muscle."},{"issue":"1","key":"255_CR65","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1152\/physrev.00019.2003","volume":"84","author":"SBP Charg\u00e9","year":"2004","unstructured":"Charg\u00e9 SBP, Rudnicki MA. Cellular and molecular regulation of muscle regeneration. Physiological Reviews. 2004;84(1):209\u201338.","journal-title":"Physiological Reviews."},{"issue":"4","key":"255_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1021\/tx100389r","volume":"24","author":"C Hu","year":"2011","unstructured":"Hu C, Eggler AL, Mesecar AD, van Breemen RB. Modification of Keap1 cysteine residues by sulforaphane. Chem Res Toxicol. 2011;24(4):515\u201321.","journal-title":"Chem Res Toxicol."},{"issue":"3","key":"255_CR67","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1124\/jpet.111.183210","volume":"338","author":"YS Hori","year":"2011","unstructured":"Hori YS, Kuno A, Hosoda R, Tanno M, Miura T, Shimamoto K, et al. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. J Pharmacol Exp Ther. 2011;338(3):784\u201394.","journal-title":"J Pharmacol Exp Ther."},{"issue":"4","key":"255_CR68","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1016-8478(23)17614-X","volume":"25","author":"Y Pan","year":"2008","unstructured":"Pan Y, Chen C, Shen Y, Zhu C-H, Wang G, Wang X-C, et al. Curcumin alleviates dystrophic muscle pathology in mdx mice. Mol Cells. 2008;25(4):531\u20137.","journal-title":"Mol Cells."},{"issue":"1","key":"255_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"AY Berman","year":"2017","unstructured":"Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precision Onc. 2017 Dec;1(1):35.","journal-title":"NPJ Precision Onc"},{"key":"255_CR70","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jbior.2018.11.006","volume":"71","author":"J Liang","year":"2019","unstructured":"Liang J, H\u00e4nsch GM, H\u00fcbner K, Samstag Y. Sulforaphane as anticancer agent: a double-edged sword? Tricky balance between effects on tumor cells and immune cells. Advances in Biological Regulation. 2019;71:79\u201387.","journal-title":"Advances in Biological Regulation."},{"key":"255_CR71","unstructured":"Durham A, Jazrawi E, Rhodes JA, Williams C, Kilty I, Barnes P, et al. The anti-inflammatory effects of sulforaphane are not mediated by the Nrf2 pathway. European Respiratory Journal [Internet]. 2014 1 [cited 2019 Nov 17];44(Suppl 58). Available from: https:\/\/erj.ersjournals.com\/content\/44\/Suppl_58\/P3332."}],"container-title":["Skeletal Muscle"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00255-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13395-020-00255-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13395-020-00255-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,18]],"date-time":"2024-08-18T14:01:57Z","timestamp":1723989717000},"score":1,"resource":{"primary":{"URL":"https:\/\/skeletalmusclejournal.biomedcentral.com\/articles\/10.1186\/s13395-020-00255-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1186\/s13395-020-00255-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-23184\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23184\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-23184\/v1","asserted-by":"object"}]},"ISSN":["2044-5040"],"issn-type":[{"value":"2044-5040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"14 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures and experiments were performed in accordance with national and European legislation, after approval by the 1st and 2nd Institutional Animal Care and Use Committee (IACUC) in Krak\u00f3w, Poland (approval numbers: 66\/2013, 199\/2018, and 148\/2020).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}